Abstract
Genetic alterations of APC and CTNNB1 (β-catenin) have been identified in a number of human cancers including tumors arising in the colon and liver. Mutations in these genes lead to abnormal accumulation of β-catenin and constitutive activation of target genes in the Wnt signaling pathway. To clarify the precise role of accumulated β-catenin in colorectal carcinogenesis, we searched for genes involved in the β-catenin/Tcf signaling pathway by cDNA microarray. MT1–MMP (membrane-type matrix metalloproteinase) was among 84 genes that were down-regulated after β-catenin had been depleted by transduction of wild-type APC in SW480 cells. Expression of MT1–MMP was elevated in 22 of 24 colon carcinomas we examined. Reporter assays and an electromobility-shift assay revealed a DNA fragment between −1169 bp and −1163 bp in the 5′ flanking region of this gene to be a target of the β-catenin/Tcf4 complex. Our results indicate that MT1–MMP is a direct down-stream target in the Wnt signaling pathway, and that one of the ways accumulated β-catenin contributes to colorectal carcinogenesis is by transactivating this gene.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Afzal S, Lalani EN, Poulsom R, Stubbs A, Rowlinson G, Sato H, Seiki M, Stamp GW . 1998 Hum. Pathol. 29: 155–165
Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T . 1999 Am. J. Pathol. 155: 1033–1038
Brown PD, Giavazzi R . 1995 Ann. Oncol. 6: 967–974
Buttner FH, Hughes CE, Margerie D, Lichte A, Tschesche H, Caterson B, Bartnik E . 1998 Biochem. J. 333: 159–165
Cowell S, Knauper V, Stewart ML, D'Ortho MP, Stanton H, Hembry RM, Lopez-Otin C, Reynolds JJ, Murphy G . 1998 Biochem. J. 331: 453–458
Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, Polakis P, Matrisian LM . 1999 Oncogene 18: 2883–2891
d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G . 1997 Eur. J. Biochem. 250: 751–757
Fosang AJ, Last K, Fujii Y, Seiki M, Okada Y . 1998 FEBS Lett. 430: 186–190
Fujita M, Furukawa Y, Tsunoda T, Tanaka T, Ogawa M, Nakamura Y . 2001 Cancer Res. 61: 7722–7726
Ha HY, Moon HB, Nam MS, Lee JW, Ryoo ZY, Lee TH, Lee KK, So BJ, Sato H, Seiki M, Yu DY . 2001 Cancer Res. 61: 984–990
Harada T, Arii S, Mise M, Imamura T, Higashitsuji H, Furutani M, Niwano M, Ishigami S, Fukumoto M, Seiki M, Sato H, Imamura M . 1998 J. Hepatol. 28: 231–239
He TC, Chan TA, Vogelstein B, Kinzler KW . 1999 Cell 99: 335–345
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW . 1998 Science 281: 1509–1512
Hlubek F, Jung A, Kotzor N, Kirchner T, Brabletz T . 2001 Cancer Res. 61: 8089–8093
Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ . 2000 J. Cell. Biol. 149: 1309–1323
Imanishi Y, Fujii M, Tokumaru Y, Tomita T, Kanke M, Kanzaki J, Kameyama K, Otani Y, Sato H . 2000 Hum. Pathol. 31: 895–904
Ishigaki S, Toi M, Ueno T, Matsumoto H, Muta M, Koike M, Seiki M . 1999 Jpn. J. Cancer Res. 90: 516–522
Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, Seiki M . 2001 J. Cell. Biol. 153: 893–904
Kikuchi A, Nieda M, Schmidt C, Koezuka Y, Ishihara S, Ishikawa Y, Tadokoro K, Durrant S, Boyd A, Juji T, Nicol A . 2001 Br. J. Cancer 85: 741–746
Kinoshita T, Sato H, Okada A, Ohuchi E, Imai K, Okada Y, Seiki M . 1998 J. Biol. Chem. 273: 16098–16103
Knauper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G . 1996 J. Biol. Chem. 271: 17124–17131
Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H . 1997 Science 275: 1784–1787
Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Quaranta V . 2000 J. Cell. Biol. 148: 615–624
Lin YM, Ono K, Satoh S, Ishiguro H, Fujita M, Miwa N, Tanaka T, Tsunoda T, Yang KC, Nakamura Y, Furukawa Y . 2001 Cancer Res. 61: 6345–6349
Lohi J, Lehti K, Valtanen H, Parks WC, Keski-Oja J . 2000 Gene 242: 75–86
Maekawa R, Maki H, Wada T, Yoshida H, Nishida-Nishimoto K, Okamoto H, Matsumoto Y, Tsuzuki H, Yoshioka T . 2000 Clin. Exp. Metastasis 18: 61–66
Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M, Bodmer WF, Moyer MP, Riecken EO, Buhr HJ, Hanski C . 1999 Proc. Natl. Acad. Sci. USA 96: 1603–1608
Mimori K, Ueo H, Shirasaka C, Mori M . 2001 Oncol. Rep. 8: 401–403
Miwa N, Furuse M, Tsukita S, Niikawa N, Nakamura Y, Furukawa Y . 2001 Oncol. Res. 12: 469–476
Miyamori H, Takino T, Kobayashi Y, Tokai H, Itoh Y, Seiki M, Sato H . 2001 J. Biol. Chem. 276: 28204–28211
Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW . 1997 Science 275: 1787–1790
Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P . 1995 Proc. Natl. Acad. Sci. USA 92: 3046–3050
Nabeshima K, Inoue T, Shimao Y, Okada Y, Itoh Y, Seiki M, Koono M . 2000 Cancer Res. 60: 3364–3369
Nagase H, Woessner Jr JF . 1999 J. Biol. Chem. 274: 21491–21494
Nakahara H, Howard L, Thompson EW, Sato H, Seiki M, Yeh Y, Chen WT . 1997 Proc. Natl. Acad. Sci. USA 94: 7959–7964
Nakamura Y, Hamada F, Ishidate T, Anai K, Kawahara K, Toyoshima K, Akiyama T . 1998 Genes Cell 3: 395–403
Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM . 2000 J. Clin. Oncol. 18: 1135–1149
Newell KJ, Witty JP, Rodgers WH, Matrisian LM . 1994 Mol. Carcinog. 10: 199–206
Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y . 1997 J. Biol. Chem. 272: 2446–2451
Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P, Basset P . 1995 Proc. Natl. Acad. Sci. USA 92: 2730–2734
Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P . 1996 Science 272: 1023–1026
Rudek MA, Figg WD, Dyer V, Dahut W, Turner ML, Steinberg SM, Liewehr DJ, Kohler DR, Pluda JM, Reed E . 2001 J. Clin. Oncol. 19: 584–592
Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M . 1994 Nature 370: 61–65
Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y . 2000 Nat. Genet. 24: 245–250
Seiki M . 1999 Apmis 107: 137–143
Shimada T, Nakamura H, Yamashita K, Kawata R, Murakami Y, Fujimoto N, Sato H, Seiki M, Okada Y . 2000 Clin. Exp. Metastasis 18: 179–188
Tetsu O, McCormick F . 1999 Nature 398: 422–426
Tsunezuka Y, Kinoh H, Takino T, Watanabe Y, Okada Y, Shinagawa A, Sato H, Seiki M . 1996 Cancer Res. 56: 5678–5683
Van der Heyden MA, Rook MB, Hermans MM, Rijksen G, Boonstra J, Defize LH, Destree OH . 1998 J. Cell. Sci. 111: 1741–1749
Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R, Clevers H, Pals ST . 1999 Am. J. Pathol. 154: 515–523
Yamamoto H, Kishida S, Kishida M, Ikeda S, Takada S, Kikuchi A . 1999 J. Biol. Chem. 274: 10681–10684
Yoshimoto M, Itoh F, Yamamoto H, Hinoda Y, Imai K, Yachi A . 1993 Int. J. Cancer 54: 614–618
Acknowledgements
We are grateful to Tae Makino and Yuka Yamane-Tanaka for technical assistance. This work was supported in part by Research for the Future Program Grant (00L01402) from the Japan Society for the Promotion of Science.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takahashi, M., Tsunoda, T., Seiki, M. et al. Identification of membrane-type matrix metalloproteinase-1 as a target of the β-catenin/Tcf4 complex in human colorectal cancers. Oncogene 21, 5861–5867 (2002). https://doi.org/10.1038/sj.onc.1205755
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205755
Keywords
This article is cited by
-
The role of MMP-14 in ovarian cancer: a systematic review
Journal of Ovarian Research (2021)
-
Roles of β-catenin, TCF-4, and survivin in nasopharyngeal carcinoma: correlation with clinicopathological features and prognostic significance
Cancer Cell International (2019)
-
N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer
BMC Cancer (2018)
-
NECAB3 Promotes Activation of Hypoxia-inducible factor-1 during Normoxia and Enhances Tumourigenicity of Cancer Cells
Scientific Reports (2016)
-
A novel role for the tumour suppressor Nitrilase1 modulating the Wnt/β-catenin signalling pathway
Cell Discovery (2016)